
Drugmakers sue Trump over prices in TV ads
pharmafile | June 17, 2019 | News story | Sales and Marketing | Amgen, Eli Lilly, HHS, MSD, Merck, Trump, pharma
Amgen, Eli Lilly and MSD have sued the Trump administration to try and block measures to force pharma companies to include prices in TV ads.
Three of America’s biggest drugmakers filed a lawsuit against the Trump administration over the Department of Health and Human Services (HHS) ruling to force pharmaceutical companies to list the prices of their drugs in adverts on TV.
Amgen, Merck and Eli Lilly have said the HHS does not have the legal power to force drugmakers to include prices and that the measure would cause confusion for patients.
“Americans deserve accurate information about the price they will pay for prescription drugs,” the lawsuit says.
“This case involves a rule adopted by the Department of Health and Human Services (HHS) that purports to further that objective, but will instead frustrate it—by misleading patients about their out-of-pocket costs for prescription drugs in a manner that even HHS admits may “confuse” and “intimidate” patients, “discourage patients from using beneficial medications, reduce access, and potentially increase total cost of care.”
Amgen commented in a statement: “Not only does the rule raise serious freedom of speech concerns, it mandates an approach that fails to account for differences among insurance, treatments, and patients themselves, by requiring disclosure of list price.”
Louis Goss
Related Content

Pharma sees climate disruption as growing supply-chain risk
Nine in ten pharmaceutical companies across the UK and G7 countries expect climate-related disruption to …

AI in pharma: From lab development to patient impact
In the decade to 2025, AI use in vaccine development has increased markedly but is …

Lilly opens fourth US Gateway Labs site
Eli Lilly has opened its newest Lilly Gateway Labs (LGL) site in San Diego, California, …





